Wai Chun Bio-Technology Limited (HKG:0660)
Hong Kong
· Delayed Price · Currency is HKD 0.0860
+0.0140 (19.44%)
Apr 22, 2025, 4:08 PM HKT
Wai Chun Bio-Technology Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 340.8 | 370.07 | 773.65 | 671.46 | 495.38 | 567.55 | Upgrade
|
| Revenue Growth (YoY) | -39.02% | -52.17% | 15.22% | 35.55% | -12.72% | -2.02% | Upgrade
|
| Cost of Revenue | 302.28 | 335.89 | 723.24 | 611.33 | 457.8 | 518.62 | Upgrade
|
| Gross Profit | 38.52 | 34.18 | 50.41 | 60.12 | 37.58 | 48.93 | Upgrade
|
| Selling, General & Admin | 33.94 | 32.73 | 35.87 | 41.33 | 36.81 | 37.7 | Upgrade
|
| Other Operating Expenses | -1 | -1.26 | -0.32 | 0.15 | 0.23 | 0.3 | Upgrade
|
| Operating Expenses | 48.03 | 36.88 | 38.5 | 42.13 | 35.95 | 34.93 | Upgrade
|
| Operating Income | -9.51 | -2.7 | 11.92 | 17.99 | 1.62 | 14 | Upgrade
|
| Interest Expense | -19.45 | -17.91 | -17.11 | -13.97 | -12.82 | -7.92 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.04 | 0.02 | - | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 2.66 | - | -4.65 | Upgrade
|
| EBT Excluding Unusual Items | -28.95 | -20.6 | -5.16 | 6.71 | -11.2 | 1.46 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.03 | - | -0.04 | Upgrade
|
| Asset Writedown | -57.57 | -57.57 | -0.54 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -4.22 | - | 0.19 | Upgrade
|
| Pretax Income | -86.52 | -78.17 | -5.7 | 2.52 | -11.2 | 1.61 | Upgrade
|
| Income Tax Expense | -11.79 | -12.46 | 4.36 | 3.44 | 1.45 | 0.62 | Upgrade
|
| Earnings From Continuing Operations | -74.73 | -65.71 | -10.06 | -0.93 | -12.65 | 1 | Upgrade
|
| Minority Interest in Earnings | 23.59 | 21.5 | -5.37 | -13.44 | -4.38 | -9.14 | Upgrade
|
| Net Income | -51.14 | -44.21 | -15.43 | -14.36 | -17.03 | -8.15 | Upgrade
|
| Net Income to Common | -51.14 | -44.21 | -15.43 | -14.36 | -17.03 | -8.15 | Upgrade
|
| Shares Outstanding (Basic) | 171 | 171 | 169 | 168 | 167 | 166 | Upgrade
|
| Shares Outstanding (Diluted) | 171 | 171 | 169 | 168 | 167 | 166 | Upgrade
|
| Shares Change (YoY) | 1.51% | 1.51% | 0.78% | 0.14% | 0.90% | - | Upgrade
|
| EPS (Basic) | -0.30 | -0.26 | -0.09 | -0.09 | -0.10 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.30 | -0.26 | -0.09 | -0.09 | -0.10 | -0.05 | Upgrade
|
| Free Cash Flow | 11.68 | 12.05 | 20.71 | -8.01 | -9.7 | -12.96 | Upgrade
|
| Free Cash Flow Per Share | 0.07 | 0.07 | 0.12 | -0.05 | -0.06 | -0.08 | Upgrade
|
| Gross Margin | 11.30% | 9.24% | 6.52% | 8.95% | 7.58% | 8.62% | Upgrade
|
| Operating Margin | -2.79% | -0.73% | 1.54% | 2.68% | 0.33% | 2.47% | Upgrade
|
| Profit Margin | -15.01% | -11.95% | -1.99% | -2.14% | -3.44% | -1.44% | Upgrade
|
| Free Cash Flow Margin | 3.43% | 3.26% | 2.68% | -1.19% | -1.96% | -2.28% | Upgrade
|
| EBITDA | 2.53 | 6.44 | 21.44 | 24.44 | 7.67 | 19.07 | Upgrade
|
| EBITDA Margin | 0.74% | 1.74% | 2.77% | 3.64% | 1.55% | 3.36% | Upgrade
|
| D&A For EBITDA | 12.04 | 9.14 | 9.52 | 6.45 | 6.04 | 5.07 | Upgrade
|
| EBIT | -9.51 | -2.7 | 11.92 | 17.99 | 1.62 | 14 | Upgrade
|
| EBIT Margin | -2.79% | -0.73% | 1.54% | 2.68% | 0.33% | 2.47% | Upgrade
|
| Effective Tax Rate | - | - | - | 136.80% | - | 38.24% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.